as of 07-17-2026 3:55pm EST
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | DEER PARK |
| Market Cap: | 872.7M | IPO Year: | 2018 |
| Target Price: | $39.33 | AVG Volume (30 days): | 406.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.05 | EPS Growth: | N/A |
| 52 Week Low/High: | $13.78 - $39.48 | Next Earning Date: | 05-14-2026 |
| Revenue: | $79,950,000 | Revenue Growth: | 104.94% |
| Revenue Growth (this year): | 40.9% | Revenue Growth (next year): | 47.23% |
| P/E Ratio: | 741.40 | Index: | N/A |
| Free Cash Flow: | 10.2M | FCF Growth: | +980.70% |
Machine learning model trained on 25+ technical indicators
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
10% Owner
Avg Cost/Share
$37.54
Shares
28,315
Total Value
$1,063,032.88
Owned After
40,000
10% Owner
Avg Cost/Share
$38.37
Shares
26,685
Total Value
$1,023,978.17
Owned After
40,000
10% Owner
Avg Cost/Share
$38.00
Shares
10,000
Total Value
$380,000.00
Owned After
40,000
SEC Form 4
10% Owner
Avg Cost/Share
$37.39
Shares
90,000
Total Value
$3,364,659.00
Owned After
40,000
Director
Avg Cost/Share
$32.48
Shares
50,000
Total Value
$1,623,795.00
Owned After
0
SEC Form 4
President & CEO
Avg Cost/Share
$32.28
Shares
120,000
Total Value
$3,825,716.92
Owned After
833,694
Chief Business Officer
Avg Cost/Share
$31.47
Shares
19,679
Total Value
$619,374.88
Owned After
25,249
SEC Form 4
Chief Business Officer
Avg Cost/Share
$31.49
Shares
37,524
Total Value
$1,181,732.07
Owned After
25,249
SEC Form 4
Chief Business Officer
Avg Cost/Share
$34.03
Shares
42,797
Total Value
$1,428,816.29
Owned After
25,249
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | ETON | 10% Owner | Jul 14, 2026 | Sell | $37.54 | 28,315 | $1,063,032.88 | 40,000 | |
| Opaleye Management Inc. | ETON | 10% Owner | Jul 7, 2026 | Sell | $38.37 | 26,685 | $1,023,978.17 | 40,000 | |
| Opaleye Management Inc. | ETON | 10% Owner | Jul 6, 2026 | Sell | $38.00 | 10,000 | $380,000.00 | 40,000 | |
| Opaleye Management Inc. | ETON | 10% Owner | Jul 2, 2026 | Sell | $37.39 | 90,000 | $3,364,659.00 | 40,000 | |
| Adams Jennifer McKie | ETON | Director | Jun 17, 2026 | Sell | $32.48 | 50,000 | $1,623,795.00 | 0 | |
| BRYNJELSEN SEAN | ETON | President & CEO | May 28, 2026 | Sell | $32.28 | 120,000 | $3,825,716.92 | 833,694 | |
| Krempa David | ETON | Chief Business Officer | May 27, 2026 | Sell | $31.47 | 19,679 | $619,374.88 | 25,249 | |
| Krempa David | ETON | Chief Business Officer | May 26, 2026 | Sell | $31.49 | 37,524 | $1,181,732.07 | 25,249 | |
| Krempa David | ETON | Chief Business Officer | May 22, 2026 | Sell | $34.03 | 42,797 | $1,428,816.29 | 25,249 |
SEC 8-K filings with transcript text
May 14, 2026 · 100% conf.
1D
+9.79%
$32.89
5D
+13.71%
$34.07
20D
+18.91%
$35.62
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.c706d217.1784333300.cc8c5f73
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
Mar 19, 2026
SEC.gov | Request Rate Threshold Exceeded
U.S. Securities and Exchange Commission
You’ve Exceeded the SEC’s Traffic Limit
Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.
Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.
The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.
For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.
For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.
Reference ID: 0.c706d217.1784333302.cc8c8e69
More Information
Internet Security Policy
By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.
Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).
To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.
If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.
Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.
Note: We do not offer technical support for developing or debugging scripted downloading processes.
Nov 6, 2025 · 100% conf.
1D
-4.14%
$18.28
Act: -11.37%
5D
-9.39%
$17.28
Act: -11.48%
20D
-12.04%
$16.77
Act: -14.73%
eton20250819_8k.htm
false 0001710340
0001710340
2025-11-06 2025-11-06
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
November 6, 2025
Date of Report (Date of earliest event reported)
(Exact name of registrant as specified in its charter)
Delaware
001-38738
37-1858472
(State
(Commission
(I.R.S. Employer
of incorporation)
File Number)
Identification Number)
21925 W. Field Parkway, Suite 235
Deer Park, Illinois 60010-7278
(Address of principal executive offices) (Zip code)
(847) 787-7361
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading symbol(s)
Name of each exchange on which registered
Common Stock, par value $0.001 per share
NASDAQ Global Market
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition.
On November 6, 2025, Eton Pharmaceuticals, Inc. issued a press release announcing its financial results for the third quarter ended September 30, 2025. A copy of the press release is attached hereto as Exhibit 99.1.
The information in this Item 2.02 and the attached Exhibit 99.1 are being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in this Item 2.02 and the attached exhibit shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended.
Discussion of Non-GAAP Financial Measures
In the Press Release, we present certain financial information, specifically Adjusted EBITDA, which is not in accordance with generally accepted accounting principles (“U.S. GAAP”). We present Adjusted EBITDA in the Press Release because this metric assists us in comparing our performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Our management uses Adjusted EBITA:
● for planning purposes, including the preparation of our annual operating budget and developing and refining our internal projections for future periods;
● to evaluate the effectiveness of our business strategies and as a supplemental tool in evaluating our performance against our budget for each period;
● in communication with our board of directors and investors concerning our financial performance;
● to evaluate prior acquisitions in relation to the existing business; and
● to evaluate comparative net sales performance in prior and future periods.
We believe that the disclosure of Adjusted EBITDA offers an additional financial metric which, when coupled with U.S. GAAP results and the reconciliation to U.S. GAAP results, provides a more complete understanding of our results of operations and the factors and trends affecting our business for securities analysts, investors and other interested parties in the evaluation of our company. We believe Adjusted EBITDA is useful to investors for the following reasons:
● Adjusted EBITDA and similar non-GAAP measures are widely used by investors to measure a company’s operating performance without regard to items that can vary substantially from company to company depending upon financing and accounting methods, book values of assets, tax jurisdictions, capital structures and the methods by which assets were acquired; and
● by comparing our Adjusted EBITDA in different historical periods, our investors can evaluate our operating performance excluding the impact of certain items.
Item 9.01 Financial Statements and Exhibits
Exhibit 99.1
Press Release issued by Eton Pharmaceuticals, Inc. on November 6, 2025 relating to financial results
104
Cover Page Interac
See how ETON stacks up against similar companies in the market
Enhance your trading experience with our free tools
The information presented on this page, "ETON Eton Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.